Command Palette

Search for a command to run...

Clinical Trials · NCT02473406

Thymosin Alpha 1 in the Prevention of Pancreatic Infection Following Acute Necrotizing Pancreatitis

Phase
Phase 4
Recruitment status
Completed
Sponsor
Weiqin Li
Enrollment
508
Start date
Mar 2018
Locations
2 sites, China
Primary endpoint
Occurrence of pancreatic infection:
View Thymosin-Alpha-1 compound reference